2-cyclopropyl-5-{[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]methyl}-1,3,4-thiadiazole
Structure Info
- Chemspace ID
- CSSB02161347693 (In-Stock Building Blocks)
- IUPAC Name
- 2-cyclopropyl-5-{[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]methyl}-1,3,4-thiadiazole
- Mol formula
- C15H21BN4O2S
- Mol weight
- 332 Da
- Catalog Number(s)
- BBLS02161347693, BBV-242795720, EN300-54487504, bbls02161347693
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 2.2
- Heavy atoms count
- 23
- Rotatable bond count
- 4
- Number of rings
- 4
- Carbon bond saturation, Fsp3
- 0.666
- Polar surface area (Å)
- 62
- Hydrogen bond acceptors count
- 5
- Hydrogen bond donors count
- 0
![Chemical structure of 2-cyclopropyl-5-{[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]methyl}-1,3,4-thiadiazole (C15H21BN4O2S) - CSSB02161347693](/st/structure/200/05efdcff444ed3542cfcf54a6e03b083/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCN%2528CC2%253DNN%253DC%2528S2%2529C2CC2%2529N%253DC1.png "C15H21BN4O2S")
- Zoom the structure
- CSSB02161347693
Items Overall 8 items from 1 supplier
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 50 mg | 935.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 100 mg | 979.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 250 mg | 1,024.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 500 mg | 1,068.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 1 g | 1,113.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 2.5 g | 2,185.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 5 g | 3,231.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 10 g | 4,791.00 |
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
Similarity Analogs
![Chemical structure of 2-methyl-5-{[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]methyl}-1,3,4-thiadiazole - CSSB00120463441](/st/structure/200/e687f30b291fbc37d0b492886b2d79c1/CC1%253DNN%253DC%2528CN2C%253DC%2528C%253DN2%2529B2OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O2%2529S1.png)
![Chemical structure of 2-cyclopropyl-5-[(4-methoxy-1H-pyrazol-1-yl)methyl]-1,3,4-thiadiazole - CSSB01994030816](/st/structure/200/aab6cb3a5b290f866db37dc566ef41f3/COC1%253DCN%2528CC2%253DNN%253DC%2528C3CC3%2529S2%2529N%253DC1.png)
![Chemical structure of 1-(2-{bicyclo[3.1.0]hexan-3-yl}ethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole - CSSB14898574711](/st/structure/200/03426c44dad6ff0a15751f2bd6cb9326/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529c2cnn%2528CCC3CC4CC4C3%2529c2.png)
![Chemical structure of 1-[2-(4,4-dimethylcyclohexyl)ethyl]-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole - CSSB06362573744](/st/structure/200/4a81cd949e8cd5e2e0cf8dcd52b370d4/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529c2cnn%2528CCC3CCC%2528C%2529%2528C%2529CC3%2529c2.png)
![Chemical structure of 1-[2-(2,3-dihydro-1H-inden-2-yl)ethyl]-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole - CSSB14875191917](/st/structure/200/b8a431cf34018311c35f1961fd79a916/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529c2cnn%2528CCC3Cc4ccccc4C3%2529c2.png)
